Mr. Klein has extensive experience representing clients in Asia and the U.S. in internal investigations, regulatory enforcement actions and compliance matters involving the U.S. Foreign Corrupt Practices Act (FCPA) and other aspects of U.S. law. He has represented companies and their boards in active investigations by federal regulators, internal company investigations, and reviews of company compliance policies and internal controls.
Mr. Klein also has broad experience conducting due diligence reviews and advising on regulatory and compliance aspects of major transactions, including acquisitions, investments and joint ventures, with a particular focus on transactions involving assets in East Asia. He has represented clients and conducted investigations in a variety of industries, including manufacturing, pharmaceuticals, health care, medical devices, automotive, technology, telecommunications and financial services, among others.
Mr. Klein also has broad experience in handling an array of complex U.S. litigation for clients in Asia and the United States, including actions brought under U.S. federal securities laws, the False Claims Act (FCA), the Racketeer Influenced and Corrupt Organizations Act (RICO) and the Alien Tort Statute (ATS), as well as other claims based on federal and state statutory and common law.
Mr. Klein has been listed in Chambers Global and Chambers Asia-Pacific every year since 2015. He speaks fluent Mandarin Chinese. Prior to entering law school, he studied in Beijing on a Fulbright Scholarship.
Mr. Klein’s representations include:
multiple companies in various industries in FCPA compliance matters and internal investigations of alleged FCPA violations in Asia;
Asian and U.S.-based companies in U.S. securities class actions;
Asian and U.S.-based companies in anti-corruption and regulatory due diligence for major transactions, and in the negotiation of associated contract provisions;
companies in complex U.S. federal litigations arising under RICO, the Alien Tort Statute and the False Claims Act;
companies in internal investigations of alleged financial or accounting misconduct; and
an individual victim of human trafficking in a two-week federal jury trial to recover compensation for years of forced labor (representation was pro bono).